At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 95 enrolled
Drug / intervention
PRP+Artz group +1 morecombination
Likely dose
PRP+Artz group 2.5 mlfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparing Efficacy of Platelet-rich Plasma (PRP) Combined With Different Hyaluronan for the Treatment of Knee Osteoarthritis: a Randomized Control Trial
In Brief
A Phase 3 clinical trial evaluating PRP+Artz group and PRP+ HYAJOINT Plus group for Knee Osteoarthritis. Completed, enrolled 95 participants across 1 site.
Detailed Summary
Either PRP or HA is each effective for treating knee OA. However, the efficacy of combined PRP and HA injections remains unknown clinically.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsKnee Osteoarthritis
CountriesTaiwan
Collaborators--
Timeline
Phase 3CompletedFinished
2020202120222023202420252026
Enrollment StartJul 2019
Primary CompletionJun 2020
First PostedJun 2021
TodayJul 2026
First PostedJun 18, 2021
Enrollment StartJul 1, 2019
Primary CompletionJun 30, 2020
TodayJul 2, 2026
Enrollment to primary: 12 monthsPosted 5.0 years ago
Interventions
PRP+Artz groupcombination
The patients in the PRP+Artz group received one intraarticular Artz injection (2.5 ml) followed consecutively by one intraarticular injection of PRP (3ml).
PRP+ HYAJOINT Plus groupcombination
The patients in the PRP+HYAJOINT Plus group received one intraarticular HYAJOINT Plus injection (3ml) followed by one intraarticular injection of PRP (3ml).